These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8474283)

  • 1. [Treatment of chronic persistent severe asthma: role of methotrexate].
    García Río FJ; Vázquez M; Satué JL
    Med Clin (Barc); 1993 Mar; 100(10):384-8. PubMed ID: 8474283
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate for the treatment of chronic corticosteroid-dependent asthma.
    Reid DJ; Segars LW
    Clin Pharm; 1993 Oct; 12(10):762-7. PubMed ID: 8258256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenotypes of severe persistent asthma in adults].
    Janin S; Rochat T
    Rev Med Suisse; 2007 Nov; 3(134):2663-7. PubMed ID: 18159700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of synergic therapy].
    Płusa T; Lubiński W
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
    Knarborg M; Hilberg O; Dahl R
    Ugeskr Laeger; 2014 Apr; 176(15):. PubMed ID: 25350142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J
    J Am Acad Nurse Pract; 2007 Sep; 19(9):459-70. PubMed ID: 17760570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory treatment of asthma in children. What strategy is appropriate?
    Frazier CA
    N C Med J; 1995 Dec; 56(12):616-8. PubMed ID: 8584059
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulatory and biologic therapies for severe refractory asthma.
    Polosa R; Morjaria J
    Respir Med; 2008 Nov; 102(11):1499-510. PubMed ID: 19012848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. What is the preferred treatment for a child with mild persistent asthma?
    Labruzzo BA; Edgerton L; Rideout S; Heintzman J
    J Fam Pract; 2007 Feb; 56(2):137-9. PubMed ID: 17270121
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
    Knarborg M; Hilberg O; Dahl R
    Ugeskr Laeger; 2015 Jun; 177(24):1159-63. PubMed ID: 26554054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based pharmacologic treatment for mild asthma.
    Koh MS; Irving LB
    Int J Clin Pract; 2007 Aug; 61(8):1375-9. PubMed ID: 17590220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increasing the dose of inhaled corticoids].
    Devillier P
    Rev Pneumol Clin; 2003 Sep; 59(4):243-8. PubMed ID: 14705610
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of methotrexate in the management of severe steroid-dependent asthma].
    Rybus L; Droszcz W
    Wiad Lek; 1999; 52(7-8):363-6. PubMed ID: 10540582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW; Massanari M; Kianifard F; Geba GP
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids and "steroid-sparing" agents in asthma.
    N Engl J Med; 1988 Sep; 319(10):650-2. PubMed ID: 3045548
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute asthma attack].
    Rabbat A; Laaban JP
    Rev Prat; 2001 Mar; 51(5):503-10. PubMed ID: 11345558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroids and "steroid-sparing" agents in asthma.
    Cott GR; Cherniack RM
    N Engl J Med; 1988 Mar; 318(10):634-6. PubMed ID: 3344009
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe asthma: clinical and pathogenic aspects].
    Grigoraş C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):718-26. PubMed ID: 14756008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic effects of suboptimally controlled asthma.
    Bootman JL; Crown WH; Luskin AT
    Manag Care Interface; 2004 Jan; 17(1):31-6. PubMed ID: 15035598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.